Weighted Average Number of Shares Outstanding, Diluted of NORTHWEST BIOTHERAPEUTICS INC from 30 Sep 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
NORTHWEST BIOTHERAPEUTICS INC quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2010 to 30 Sep 2025.
  • NORTHWEST BIOTHERAPEUTICS INC Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 1,492,079, a 19% increase year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 1,242,237, a 11% increase from 2023.
  • NORTHWEST BIOTHERAPEUTICS INC annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1,119,191, a 10% increase from 2022.
  • NORTHWEST BIOTHERAPEUTICS INC annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1,015,852, a 0.79% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

NORTHWEST BIOTHERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,492,079 +233,547 +19% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 1,438,198 +223,882 +18% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 1,359,496 +171,347 +14% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 1,242,237 +123,046 +11% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 1,258,532 +124,173 +11% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 1,214,316 +105,896 +9.6% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 1,188,149 +113,247 +11% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 1,119,191 +103,339 +10% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 1,134,359 +93,377 +9% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 1,108,420 +104,444 +10% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 1,074,902 +115,651 +12% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 1,015,852 +7,983 +0.79% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 1,040,982 -94,780 -8.3% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 1,003,976 -155,100 -13% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 959,251 +124,646 +15% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 1,007,869 +282,740 +39% 01 Oct 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
Q3 2021 1,135,762 +388,013 +52% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 1,159,076 +461,521 +66% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 834,605 +185,747 +29% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 725,129 +160,941 +29% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 747,749 +170,619 +30% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 697,555 +100,180 +17% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 648,858 +119,725 +23% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 564,188 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 577,130 +60,830 +12% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 597,375 +172,383 +41% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 529,133 01 Jan 2019 31 Mar 2019 10-Q 24 Jun 2020 2020 Q1
Q3 2018 516,300 -280,969,700 -100% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 424,992 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q3 2017 281,486,000 +166,650,000 +145% 01 Jul 2017 30 Sep 2017 10-Q 16 Nov 2018 2018 Q3
Q3 2016 114,836,000 +25,015,000 +28% 01 Jul 2016 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q3 2015 89,821,000 +29,217,000 +48% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q3 2014 60,604,000 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q3 2012 11,029 +3,333 +43% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q3 2011 7,696 -70,405,304 -100% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2012 Q3
Q3 2010 70,413,000 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011 2011 Q3

NORTHWEST BIOTHERAPEUTICS INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 1,242,237 +123,046 +11% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 1,119,191 +103,339 +10% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 1,015,852 +7,983 +0.79% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 1,007,869 +282,740 +39% 01 Jan 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
2020 725,129 +160,941 +29% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 564,188 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.